CTI BioPharma Corp. (CTIC)
NASDAQ: CTIC
· Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM
CTI BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 75.77M | 53.95M | 32.87M | 14.62M | 2.29M | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.46M | 3.51M | 2.35M | 1.2M | 278K | n/a | 4.2M | 4.2M | 4.2M |
Gross Profit | 71.31M | 50.43M | 30.52M | 13.43M | 2.02M | n/a | -4.2M | -4.2M | -4.2M |
Operating Income | -53.93M | -79.8M | -101.57M | -112.73M | -113.36M | -95.33M | -74.75M | -62.42M | -52.91M |
Interest Income | 2.54M | 1.68M | 672K | 246K | 42K | 38K | 45K | 61K | 96K |
Pretax Income | -69.24M | -92.99M | -112.32M | -120.8M | -117.82M | -97.91M | -76.12M | -63.21M | -57.53M |
Net Income | -77.01M | -92.41M | -113.69M | -122.24M | -119.25M | -99.33M | -76.12M | -63.21M | -57.53M |
Selling & General & Admin | 88.69M | 84.83M | 85.83M | 77.99M | 66.62M | 56.2M | 36.81M | 27.2M | 20.79M |
Research & Development | 39.06M | 36.9M | 35.66M | 37.15M | 37.74M | 39.14M | 37.94M | 35.22M | 32.12M |
Other Expenses | -2.51M | 8.51M | 10.61M | 11.02M | 11.02M | n/a | -4.2M | -4.2M | -4.2M |
Operating Expenses | 125.24M | 130.23M | 132.09M | 126.17M | 115.38M | 95.33M | 74.75M | 62.42M | 52.91M |
Interest Expense | 16.77M | 13.8M | 11.47M | 8.13M | 4.33M | 2.45M | 1.26M | 841K | 933K |
Selling & Marketing Expenses | n/a | n/a | 6.85M | 6.85M | 6.85M | 6.85M | n/a | n/a | n/a |
Cost & Expenses | 129.7M | 133.75M | 134.44M | 127.36M | 115.66M | 95.33M | 74.75M | 62.42M | 52.91M |
Income Tax Expense | 7.77M | -587K | 1.36M | 1.3M | 1.3M | 1.29M | -112K | 53K | 47K |
Shares Outstanding (Basic) | 131.57M | 128.43M | 121.6M | 108.53M | 99.83M | 97.66M | 93.82M | 92.34M | 76.37M |
Shares Outstanding (Diluted) | 131.57M | 128.43M | 121.6M | 108.53M | 99.83M | 97.66M | 93.82M | 92.34M | 76.37M |
EPS (Basic) | -0.64 | -0.84 | -1.1 | -1.23 | -1.23 | -1.09 | -0.9 | -0.79 | -0.77 |
EPS (Diluted) | -0.64 | -0.84 | -1.1 | -1.23 | -1.23 | -1.09 | -0.9 | -0.79 | -0.77 |
EBITDA | -50.91M | -77.83M | -4.56M | -16.69M | -17.96M | -124K | -74.33M | -61.84M | -52.46M |
EBIT | -52.47M | -79.19M | -196.18M | -207.99M | -208.81M | -190.78M | -74.86M | -62.37M | -56.6M |
Depreciation & Amortization | 3.02M | 1.97M | 2.21M | 1.38M | 723K | 526K | 528K | 529K | 534K |